IFG Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $884K | Buy |
1,985
+3
| +0.2% | +$1.34K | 0.04% | 377 |
|
|
2025
Q1 | $961K | Hold |
1,982
| – | – | 0.05% | 332 |
|
|
2024
Q4 | $798K | Buy |
+1,982
| New | +$798K | 0.05% | 332 |
|
|
2024
Q3 | – | Sell |
-2,181
| Closed | -$1.02M | – | 619 |
|
|
2024
Q2 | $1.02M | Buy |
+2,181
| New | +$1.02M | 0.07% | 272 |
|
|
2024
Q1 | – | Sell |
-2,319
| Closed | -$944K | – | 582 |
|
|
2023
Q4 | $944K | Buy |
2,319
+14
| +0.6% | +$5.7K | 0.07% | 251 |
|
|
2023
Q3 | $802K | Buy |
+2,305
| New | +$802K | 0.07% | 256 |
|
|
2023
Q2 | – | Sell |
-2,342
| Closed | -$738K | – | 503 |
|
|
2023
Q1 | $738K | Sell |
2,342
-20
| -0.8% | -$6.3K | 0.07% | 255 |
|
|
2022
Q4 | $682K | Buy |
2,362
+29
| +1% | +$8.37K | 0.07% | 265 |
|
|
2022
Q3 | $675K | Buy |
+2,333
| New | +$675K | 0.06% | 274 |
|
|
2019
Q3 | – | Sell |
-2,264
| Closed | -$415K | – | 451 |
|
|
2019
Q2 | $415K | Buy |
2,264
+47
| +2% | +$8.62K | 0.07% | 225 |
|
|
2019
Q1 | $407K | Sell |
2,217
-158
| -7% | -$29K | 0.08% | 220 |
|
|
2018
Q4 | $393K | Buy |
2,375
+2
| +0.1% | +$331 | 0.09% | 209 |
|
|
2018
Q3 | $457K | Sell |
2,373
-12
| -0.5% | -$2.31K | 0.09% | 226 |
|
|
2018
Q2 | $405K | Buy |
2,385
+142
| +6% | +$24.1K | 0.08% | 227 |
|
|
2018
Q1 | $365K | Sell |
2,243
-5
| -0.2% | -$814 | 0.08% | 232 |
|
|
2017
Q4 | $336K | Buy |
+2,248
| New | +$336K | 0.08% | 243 |
|